Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
05/2005
05/26/2005US20050112725 Secreted and transmembrane polypeptides and nucleic acids encoding the same
05/26/2005US20050112692 Screening peptide library; incubation complexing
05/26/2005US20050112574 Isolated nucleic acid; angiogenesis inhibitor
05/26/2005US20050112565 Proteases
05/26/2005US20050112206 Mixture of drug, aminoacrylate polymer and acid
05/26/2005US20050112197 Celecoxib dissolving in polyethylene glycol; antiinflammatory agents, osteoporosis, respiratory system disorders, antitumor agents, analgesics
05/26/2005CA2545781A1 Bicyclic pyrazolone cytokine inhibitors
05/26/2005CA2545060A1 Methods of use of thrombin receptor antagonists
05/26/2005CA2544308A1 Cytokine antagonist molecules
05/26/2005CA2544247A1 Hydroxyalkyl substituted pyrido-7-pyrimidin-7-ones
05/26/2005CA2543926A1 Use of an inhibitor of csf-1 activity for the treatment of inflammatory bowel disease
05/25/2005EP1533294A1 Beta-alanine derivative and use thereof
05/25/2005EP1532251A1 Human acid sensing ion channel 2b (hasic2b), process for producing the same, and its use
05/25/2005EP1532250A1 Fcyriia transgenic animal model for autoimmune disease
05/25/2005EP1532242A2 Methods for preparing purified prostaglandin e synthase
05/25/2005EP1532150A1 Novel purine derivatives, production and use thereof as medicaments
05/25/2005EP1532148A1 Novel purine- or pyrrolol(2,3-d)pyrimidine-2-carbonitiles for treating diseases associated with cysteine protease activity
05/25/2005EP1532145A1 Pyrazole compositions useful as inhibitors of gsk-3
05/25/2005EP1532135A1 Nf-kb inhibitors
05/25/2005EP1532133A1 Nf-:b inhibitors
05/25/2005EP1532121A1 New use of pyrimidine - or triazine- 2-carbonitiles for treating diseases associated with cysteine protease activity and novel pyrimidine-2-carbonitile derivatives
05/25/2005EP1532113A2 Substituted hihydroquinolines as glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
05/25/2005EP1532111A1 2,5-disubstituted 3-mercaptopentanoic acid
05/25/2005EP1532104A1 Crystalline beta-2 adrenergic receptor agonist
05/25/2005EP1531904A1 Combination of an allosteric inhibitor of matrix metalloproteinase-13 with a selective inhibitor of cyclooxygenase-2 that is not celecoxib or valdecoxib
05/25/2005EP1531867A1 Metastable pharmaceutical compositions
05/25/2005EP1531866A1 Pharmaceutical products and compositions comprising specific anticholinergic agents, beta-2 agonists and corticosteroids
05/25/2005EP1531847A2 Pharmaceutical formulation
05/25/2005EP1531841A1 Probiotics for gut neuromuscular functions
05/25/2005EP1531837A1 Compositions and methods for the prophylaxis and treatment of aphthous ulcers and herpes simplex lesions
05/25/2005EP1531830A1 Method for reducing c-rective protein levels with non-antibacterial tetracycline formulations
05/25/2005EP1531822A1 1-aryl-4-substituted piperazine derivatives for use as ccr1 antagonists for the treatment of inflammation and immune disorders
05/25/2005EP1531819A1 USE OF I kappa B KINASE INHIBITORS FOR THE TREATMENT OF PAIN
05/25/2005EP1531818A1 Topical treatment of skin diseases
05/25/2005EP1531817A1 Glycinamide derivatives as raf-kinase inhibitors
05/25/2005EP1531812A1 Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of i.a. rheumatoid arthristis
05/25/2005EP1531808A1 Peroxynitrite rearrangement catalysts used for the treatment or prophylaxis of diseases caused by peroxynitrite-mediated reactions
05/25/2005EP1531800A2 Stealth lipid nanocapsules, methods for the preparation thereof and use thereof as a carrier for active principle(s)
05/25/2005EP1531793A1 Ophtalmic ointment composition comprising a drug, an ointment base and a solubiling/dispersing agent
05/25/2005EP1531791A2 Prevention and reduction of blood loss
05/25/2005EP1531716A2 Methods for using adamts-12, an integrin and metalloprotease with thrombospondin motifs
05/25/2005EP1341791B1 Thioether substituted imidazoquinolines
05/25/2005EP1286673B1 Ligands of integrin receptors
05/25/2005EP1282592B1 Use of amines
05/25/2005EP1279039A4 Diagnostic assay and method of treatment involving macrophage inhibitory cytokine -1 (mic-1)
05/25/2005EP1165615B1 MONOCLONAL ANTIBODIES AGAINST HUMAN PROTEIN Mcm3, PROCESS FOR THEIR PRODUCTION, AND THEIR USE
05/25/2005EP1140814B1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
05/25/2005EP1093371B1 Use of fk506 and related macrolides in the manufacture of a medicament for treatment or prevention of pain
05/25/2005EP1039911B1 MORPHOLINO-N-ETHYL ESTER PRODRUGS OF INDOLE sPLA 2 INHIBITORS
05/25/2005EP0994903B1 Methods and compositions for galactosylated glycoproteins
05/25/2005EP0946511B1 Novel compounds with analgesic effect
05/25/2005EP0907652B1 Immunosuppressive compounds and methods
05/25/2005EP0880362B1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene b 4 receptor antagonist
05/25/2005EP0836613B1 Water-soluble adenosine kinase inhibitors
05/25/2005CN1620467A Secreted protein
05/25/2005CN1620466A Cystine-knot fold protein
05/25/2005CN1620461A 2-amino-propanol derivatives
05/25/2005CN1620459A 稠合双环嘧啶衍生物 Fused bicyclic pyrimidine derivative
05/25/2005CN1620452A 3, 4-dihydro-1h-isoquinoloin-2-yl-derivatives
05/25/2005CN1620451A Benzhydryl derivatives
05/25/2005CN1620448A Piperidine-2, 6-diones heterocyclically substituted in the 3-position
05/25/2005CN1620442A Five-membered-ring compound
05/25/2005CN1620435A 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
05/25/2005CN1620434A Pyrrolidine-2-ones as factor Xa inhibitors
05/25/2005CN1620431A (20s)-1alpha-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses
05/25/2005CN1620424A Compounds for the treatment of inflammatory disorders
05/25/2005CN1620419A 1-amino-alkylcyclohexanes as 5-HT3 and neuronal nicotinic receptor antagonists
05/25/2005CN1620414A 维生素d类似物 Vitamin d analogues
05/25/2005CN1620314A Gas micro-liposome compound
05/25/2005CN1620311A Therapeutic agent
05/25/2005CN1620309A Novel pharmaceutical composition of interferon gamma or pirfenidone with molecular diagnostics for the improved treatment of interstitial lung diseases
05/25/2005CN1620303A Skin perparation for external use containing purpuricenus temminckii frass as the active ingredient
05/25/2005CN1620301A Pharmaceutically acceptable phosphate-glycerol carrying bodies
05/25/2005CN1620299A Alpha-hydroxy-2-methylene-10-nor-pregnacalciferol and its uses
05/25/2005CN1620291A 3-(imidazolyl)-2-alkoxypropanoic acids as TAFIA inhibitors
05/25/2005CN1620288A Pharmaceutical use of COX-2 inhibitors in angiogenesis-mediated ocular disorders
05/25/2005CN1620283A Dispersions for formulating slightly or poorly soluble active ingredients
05/25/2005CN1618811A Cell surface molecule mediating cell adhesion and signal transmission
05/25/2005CN1618442A Ointment for treating rheumatic disease
05/25/2005CN1203087C Factor VIIa inhibitors
05/25/2005CN1203071C Polysaccharidic esters of N-derivatives of glutamic acid
05/25/2005CN1203070C Thrombin receptor antagonists
05/25/2005CN1203069C Substituted piperidines, medicaments containing these compounds, and methods for production thereof
05/25/2005CN1203066C (Methylsulfonyl) phenyl-2-(5H)-furanones as cos-2 inhibitors
05/25/2005CN1203058C Piperidine derivatives and drugs containing these derivatives as active ingredient
05/25/2005CN1203047C Biaryl ether derivatives useful as monoamine reuptake inhibitors
05/25/2005CN1202849C Oral liquid for nephrosis
05/25/2005CN1202828C Use of diphosphonic acid in preparing medicine for treatment of vasculogenesis
05/25/2005CN1202815C Delayed-action form of administration containing tramadol saccharinate
05/24/2005US6897319 Therapeutic drugs for treating central nervous system disorders
05/24/2005US6897318 Process for making substituted pyrazoles
05/24/2005US6897292 For detecting a genetic abnormality, cancer
05/24/2005US6897231 Jun n- terminal kinase inhibitors such as 3-(4-methoxyphenyl)-1H-indazole
05/24/2005US6897229 Use of PDE4 inhibitor N-(3,5-dichloropyrid-4-yl)-3-cyclopropylmethoxy-4-difluoromethoxybenzamide, salts or its N-oxide with PDE3 inhibitor for treatment of obstructions of bronchi
05/24/2005US6897226 NK-1 receptor active amine oxide prodrugs
05/24/2005US6897223 Nitrogen compounds such as Benzyl-8-methyl-5,7-dioxo-1,5,6,7-tetrahydro-(1,2,4)triazolo(1,5-a)pyridine -2-carboxylic acid benzylamide, used for prophylaxis of arthritis, inflammation or cancer
05/24/2005US6897219 Central nervous system diosrders; analgesics; antiinflammatory agents
05/24/2005US6897218 Nitric oxide donors based on metallic centers
05/24/2005US6897211 Thienodibenzoazulene compounds as tumor necrosis factor inhibitors
05/24/2005US6897210 Anticancer agents; antiarthritic agents
1 ... 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 ... 1272